Literature DB >> 10052556

High rates of antimicrobial resistance among clinical isolates of nontyphoidal Salmonella in Taiwan.

Y J Yang1, C C Liu, S M Wang, J J Wu, A H Huang, C P Cheng.   

Abstract

To assess trends in antimicrobial-resistant Salmonella infections from 1989 to 1996 in southern Taiwan, the minimum inhibitory concentrations (MICs) of 14 antibiotics or antibiotic combinations were determined by the agar dilution method for 297 clinical isolates of nontyphoidal Salmonella. The rates of resistance to ampicillin, chloramphenicol, and tetracycline were 65, 67, and 78%, respectively. Resistance to trimethoprim-sulfamethoxazole (TMP-SMX) increased from 25% in 1989-1992 to 35% in 1993-1996 (P=0.057). For new quinolones and extended-spectrum cephalosporins, no resistant strains were encountered. Multiple resistance to more than five antimicrobial drugs doubled from 10.6% in 1989-1992 to 19.7% in 1993-1996. Multiply resistant salmonellae were isolated more commonly from blood samples than from feces (30% vs. 14%, P<0.05). In Taiwan, ampicillin, chloramphenicol, and even TMP-SMX are no longer the drugs of choice for treatment of serious nontyphoidal Salmonella infections. Extended-spectrum cephalosporins are now the preferred drugs in Taiwan for treatment of invasive Salmonella infections in children.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10052556     DOI： 10.1007/s100960050213

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  7 in total

1.  Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase.

Authors:  M Edelstein; M Pimkin; T Dmitrachenko; V Semenov; N Kozlova; D Gladin; A Baraniak; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

Authors:  P L Winokur; A Brueggemann; D L DeSalvo; L Hoffmann; M D Apley; E K Uhlenhopp; M A Pfaller; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to production of CTX-M-14 and CMY-2 beta-lactamases.

Authors:  Wen-Chen Li; Fu-Yuan Huang; Chang-Pan Liu; Li-Chuan Weng; Nai-Yu Wang; Nan-Chang Chiu; Chuen-Sheue Chiang
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Diagnostic value of bacterial stool cultures and viral antigen tests based on clinical manifestations of acute gastroenteritis in pediatric patients.

Authors:  L-J Liu; Y-J Yang; P-H Kuo; S-M Wang; C-C Liu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

5.  Non-traumatic colon perforation in children: a 10-year review.

Authors:  Y J Chang; D C Yan; M S Kong; H C Chao; C S Huang; J Y Lai
Journal:  Pediatr Surg Int       Date:  2006-07-04       Impact factor: 1.827

6.  In vitro and in vivo intracellular killing effects of tigecycline against clinical nontyphoid Salmonella isolates using ceftriaxone as a comparator.

Authors:  Hung-Jen Tang; Wen-Chien Ko; Chi-Chung Chen; Po-Lin Chen; Han Siong Toh; Tzu Chieh Weng; Wen-Liang Yu; Shyh-Ren Chiang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

7.  Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan.

Authors:  Jing-Jou Yan; Wen-Chien Ko; Cheng-Hsun Chiu; Shu-Huei Tsai; Hsiu-Mei Wu; Jiunn-Jong Wu
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.